ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
AZ/MSD pursue wider indication for Lynparza on trial success
pharmatimes
July 04, 2018AstraZeneca and MSD have unveiled trial results showing that Lynparza significantly extended the time patients with ovarian cancer lived without their disease worsening in the first-line maintenance setting, which could significantly expand the drug’s rea
Pharma Sources Insight January 2025
